期刊文献+

一种磷酸二酯酶抑制剂异去甲蟛蜞菊内酯对HT-22细胞的保护作用 被引量:1

Protective Effect of Phosphodiesterase Inhibitor DWEL on HT-22 Cells Damage
下载PDF
导出
摘要 磷酸二酯酶(PDEs)是催化水解细胞内第二信使cAMP和cGMP的唯一途径,而磷酸二酯酶抑制剂可通过改变cAMP和cGMP的浓度从而调节学习与认知功能障碍等多种生理过程。异去甲蟛蜞菊内酯(Demethylwedelolactone,DWEL)是墨旱莲的主要成分之一。实验采用Alpha试剂盒确认DWEL对PDE2A有一定的抑制作用,其IC50为9.17μmol·L^-1;而对PDE4D和PDE10A无明显抑制作用,说明DWEL对磷酸二酯酶的抑制具有一定选择性。可的松诱导HT-22细胞模型发现,不同浓度的DWEL给药后细胞活力不断提高,浓度到达20μmol·L^-1时,细胞活力为76.98%(P<0.05),结果表明DWEL对神经细胞有一定保护作用。 Phosphodiesterase PDEs are the only pathways that catalyze the hydrolysis of second messenger cAMP and cGMP in cells.Phosphodiesterase(PDE)inhibitors can regulate learning and cognitive dysfunction(AD)by altering the concentrations of cAMP and cGMP.Demethylwedelolactone(DWEL)is one of the main components of Eclipta prostrata L.Alpha kit test confirmed the inhibition effect of Demethylwedelolactone on PDE2A with IC 50 value 9.17μmol·L^-1.However,no obvious inhibition effect was found on PDE4D and PDE10A which indicate Demethylwedelolactone can inhibit PDE2A selectively.HT-22 cell model induced by cortisone showed that Demethylwedelolactone could increase the survival rate of HT-22 cell cells.When the concentration reached 20μmol·L^-1,the cell viability was 76.98%(P<0.05).These results suggested that DWEL could protect HT-22 cell indured by cortisone.
作者 毛明强 邹婧 郑静 丁淑敏 吴香莹 周冬雷 孙毅立 MAO Mingqiang;ZOU Jing;ZHENG Jing;DING Shumin;WU Xiangying;ZHOU Donglei;SUN Yili(School of Pharmaceutical Engineering & Life Science,Changzhou University,Changzhou 213164,China)
出处 《常州大学学报(自然科学版)》 CAS 2019年第5期87-92,共6页 Journal of Changzhou University:Natural Science Edition
基金 国家自然科学基金资助项目(81603336)
关键词 磷酸二酯酶 异去甲蟛蜞菊内脂 抑制作用 神经细胞 PDEs Demethylwedelolactone inhibition nerve cells
  • 相关文献

参考文献2

二级参考文献38

  • 1孙超渊,张莉,程克棣,杜冠华,朱平.磷酸二酯酶4研究进展[J].中国药理学通报,2006,22(10):1161-1167. 被引量:19
  • 2Soderling S H, Bayuga S J, Beavo J A. Identification and characterization of a novel family of cyclic nucleotidc phosphodiesterases [J]. J Biol Chem,1998, 273(25) : 15553 -8.
  • 3Giembycz M A. Development status of second-generation PDE4 inhibitors for asthma and COPD: the story so far[ J] ? Monaldi Arch Chest Dis, 2002, 57( 1 ) :48 -64.
  • 4Losco P E, Evans E W, Barat S A, et al. The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys[ J]. Toxicol Pathol, 2004, 32 (3) :295 - 308.
  • 5Michaeli T, Bloom T J, Martins T, et al. Isolation and character- ization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae[ J]. J Biol Chem, 1993, 268 ( 17 ) : 12925 - 32.
  • 6Sasaki T, Kotera J, Yuasa K, Omori K. Identification of human PDE7B, a cAMP-specific phosphodiesterase[ J]. Biochem Biophys Res Continua, 2000, 271(3 ) : 575 - 83.
  • 7Glavas N A, Ostenson C, Schaefer J B, et al. T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3 [J].Proc Natl Acad Sci USA, 2001 , 98 ( 11 ) : 6319 - 24.
  • 8Li L, Yee C, Beavo J A. CD3- and CD8-dependent induction of PDE7 required for T cell activation [ J ]. Science, 1999, 283 (5403) :848 -51.
  • 9Hetman J M, Soderling S H, Glavas N A, Beavo J A. Cloning and characterization of PDE7B, a cAMP specific phoslShodiesterase [J]. Proc Natl Acad Sci USA, 2000, 97(1) :472 -6.
  • 10Torras-Llort M, Azorin F. Functional characterization of the hu- man phosphodiesterase 7A1 promoter [ J ]. Biochern J, 2003,373 (Pt 3) :835 -43.

共引文献43

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部